Congrats to our SOSV portfolio company VALANX Biotech on its €3 million in new funding to advance its lead antibody-drug conjugate (ADC) program. The financing...
In 2015, SOSV opened IndieBio San Francisco, Silicon Valley’s first biotech program that offered bio-labs as well as pre-seed investment to scientists ready to launch...
When SOSV and the New Jersey Economic Development Authority (NJEDA) announced a $50 million co-investment to build a new global headquarters for SOSV’s HAX in the...
Using a plant-based fermentation process, Geltor biodesigns collagen for beauty, nutrition, food, and beverage markets. Source: Geltor The New York Times recently spotlighted Geltor, an alt-protein company...
SOSV portfolio company and graduate of the IndieBio progrmam, Ten63 Therapeutics recently announced that it added strategic investment from new investors Chugai Venture Fund and...
Back in 2018, Governor Phil Murphy set out to strengthen New Jersey as a home for breakthrough innovation by building new Strategic Innovation Centers (SIC), led...
SOSV General Partner Po Bronson alongside other leading wellness industry investors spoke to Glossy about about what’s in and out when it comes to 2026...
Yesterday, Trump announced a $12B critical minerals stockpile program (“Project Vault”) to procure and store critical minerals in the U.S. SOSV General Partner Duncan Turner...